medigraphic.com
ISSN 2078-7170 (Electronic)

2015, Number 1

<< Back Next >>

CorSalud 2015; 7 (1)

Programmed electrical pacing of the heart in Brugada Syndrome. Part I: A current view

Dorantes SM, Trung CP

Language: Spanish
References: 34
Page: 46-51
PDF size: 207.58 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Foreword: Historical Perspectives. En: Josephson ME. Clinical Cardiac Electrophysiology: Techniques and interpretations. 4ta. ed. Philadelphia: Lippin-cott Williams & Wilkins; 2008. p. xi-xv.

  2. Rankin AC, Quinn FR, Rae AP. Clinical cardiac elec-trophysiology. En: Macfarlane PW, van Oosterom A, Pahlm O, Kligfield P, Janse M, Camm J, eds. Com-prehensive electrocardiology. London: Springer-Verlag; 2011. p. 1134, 1135, 1138, 1146, 1147.

  3. Janse MJ, Rosen MR. History of arrhythmias. En: Kass RS, Clancy CE, eds. Basis and treatment of cardiac arrhythmias. Handbook of experimental pharmacology. Berlin Heidelberg: Springer-Verlag; 2006. p. 1-39.

  4. Callans DJ. Patients with hemodynamically tolera-ted ventricular tachycardia require implantable car-dioverter-defibrillators. Circulation. 2007;116:1196-203.

  5. Brugada P. Estimulación eléctrica programada del corazón; indicaciones en el año 1986. Realidad y fantasia, incertidumbre y esperanza. Rev Esp Car-diol. 1986;39:327-31.

  6. Castro J, Antzelevitch C, Tornés F, Dorantes M, Dor-ticós F, Zayas R, et al. Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycar-dia/ventricular fibrillation in patients with the Brugada syndrome. J Am Coll Cardiol. 2006;47: 1828-34.

  7. Alemán-Fernández A, Dorantes-Sánchez M, Castro J, González L, Coto Y, Rodríguez M. Arritmias ven-triculares malignas en pacientes con cardiodesfibri-lador implantable: signos eléctricos premonitorios de recidivas. CorSalud [Internet]. 2014 [citado 12 May 2014];6:63-9. Disponible en: http://www.corsalud.sld.cu/sumario/2014/v6n1a14/marcadorestv.html

  8. Dorantes M. Signos eléctricos premonitorios de riesgo: ¿Cuál es el mejor? Controversia no termi-nada, en impetuoso crecimiento. CorSalud [Inter-net]. 2010 [citado 20 May 2014];2:[aprox. 6 p.]. Disponible en: http://www.corsalud.sld.cu/sumario/2010/v2n1a10/signos.htm

  9. Dorantes M, Castro J, Tornés F, Quiñones MA, Za-yas R, Dorticós F. Muerte súbita por causa eléctrica en sujetos sin enfermedad cardiaca estructural de-mostrable. Experiencia cubana. Arch Cardiol Mex. 2004;74:283-9.

  10. Huikiru HV, Mäkikallio TH, Raatikainen P, Perkiö-mäki J, Castellanos A, Myerburg RJ. Prediction of sudden cardiac death. Appraisal of the studies and methods assessing the risk of sudden arrhythmic death. Circulation. 2003;108:110-5.

  11. Nemec J, Shen WK. Invasive electrophysiologic testing: role in sudden death prediction. In: Gussak I, Antzelevitch C, eds. Electrical diseases of the heart. 2da. ed. London: Springer-Verlag; 2013. p. 271-87.

  12. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, et al. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J. 2001;22:1374-450.

  13. Aizawa Y, Naitoh N, Washizuka T, Takahashi K, Uchiyama H, Shiba M, et al. Electrophysiological findings in idiopathic recurrent ventricular fibrilla-tion: special reference to mode of induction, drug testing, and long‐term outcomes. Pacing Clin Elec-trophysiol. 1996;19:929-39.

  14. Ajiro Y, Hagiwara N, Kasanuki H. Assessment of markers for identifying patients at risk for life-threatening arrhythmic events in Brugada syn-drome. J Cardiovasc Electrophysiol. 2005;16:45-51.

  15. Anderson KP. Programmed electrical stimulation for risk assessment in Brugada syndrome. Time to change the guidelines? J Am Coll Cardiol. 2012;59: 46-8.

  16. Brugada P, Geelen P, Brugada R, Mont L, Brugada J. Prognostic value of electrophysiologic investiga-tions in Brugada syndrome. J Cardiovasc Electro-physiol. 2001;12:1004-7.

  17. Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, et al. HRS/EHRA/APHRS Expert Consensus State-ment on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm 2013;10:1932-63.

  18. Stephenson EA, Berul CI. Electrophysiological inter-ventions for inherited arrhythmia syndromes. Cir-culation. 2007;116:1062-80.

  19. López A, Dorantes M. Fibrilación ventricular idiopá-tica. Rev Cubana Cardiol Cir Cardiovasc [Internet]. 2013 [citado 20 May 2014];19:5-12. Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/download/310/323

  20. Wilde AA, Viskin S. EP testing does not predict car-diac events in Brugada syndrome. Heart Rhythm 2011;8:1598-600.

  21. Brugada P, Brugada R, Brugada J. Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation. 2005;112:279-92.

  22. Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Giordano U, et al. Natural history of Brugada syndrome. Insights for risk stratification and management. Circulation. 2002;105:1342-7.

  23. Eckardt L, Probst V, Smits JP, Bahr ES, Wolpert C, Schimpf R, et al. Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation. 2005;111:257-63.

  24. Antzelevitch C, Brugada P, Brugada J, Brugada R, eds. El Síndrome de Brugada: del laboratorio a la clínica. Barcelona: J&C Ediciones Médicas, S.L.; 2006.

  25. Brugada J, Brugada R, Brugada P. Rebuttal to EP testing does not predict cardiac events in patients with Brugada syndrome. Heart Rhythm. 2011;8: 1796.

  26. Brugada J, Brugada R, Brugada P. Electrophysiologic testing predicts events in Brugada syndrome pa-tients. Heart Rhythm. 2011;8:1595-7.

  27. Brugada R, Roberts R. Brugada syndrome. Why are there multiple answers to a simple question? Cir-culation. 2001;104:3017-9.

  28. Paul M, Gerss J, Schulze-Bahr E, Wichter T, Vahl-haus C, Wilde AA, et al. Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data. Eur Heart J. 2007;28:2126-33.

  29. Benito B, Brugada J, Brugada R, Brugada P. Síndro-me de Brugada. Rev Esp Cardiol. 2009;62:1297-315.

  30. Gussak I, Bjerregaard P, Hammill SC. Clinical diag-nosis and risk stratification in patients with Brugada syndrome. J Am Coll Cardiol. 2001;37:1635-8.

  31. Schimpf R, Borggrefe M. From ECG to mutation: programmed ventricular stimulation providing a link to genetics of cardiac channelopathies. Heart Rhythm. 2011;8:1553-4.

  32. Myerburg RJ, Marchlinski FE, Scheinman MM. Con-troversy on electrophysiology testing in patients with Brugada syndrome. Heart Rhythm. 2011;8: 1972-4.

  33. Eckardt L, Bruns HJ, Paul M, Kirchhof P, Schulze-Bahr E, Wichter T, et al. Body surface area of ST elevation and the presence of late potentials co-rrelate to the inducibility of ventricular tachy-arrhythmias in Brugada syndrome. J Cardiovasc Electrophysiol. 2002;13:742-9.

  34. Antzelevitch C, Brugada P, Brugada J, Brugada R. Brugada syndrome: from cell to bedside. Curr Probl Cardiol. 2005;30:9-54.




2020     |     www.medigraphic.com